Compugen

Compugen is a clinical-stage drug discovery and development company utilizing a broadly applicable predictive computational discovery platform to identify novel drug targets and biological pathways, focusing on developing treatments in the field of cancer immunotherapy. Recognizing the potential of immuno-oncology to transform the landscape of cancer treatment, we have chosen to concentrate on discovering new drug targets to expand the scope of cancer immunotherapies to new patient populations. Our approach is rooted in over a decade of pioneering multidisciplinary research involving the development of innovative computational methods for the discovery of novel drug targets.